8 terminated. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Terminated 8 |
Follow Tauopathies: new trials by email Literature Review of Tauopathies trials Research Report on Tauopathies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia. Transdermal Methylphenidate - Dementia, Accidental Falls | Phase 4 | Terminated | St. Louis University | 14 | 2012-11-01 | 2018-07-24 |
| Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease Nuedexta (20/10) - Alzheimer's Disease, Pseudobulbar Affect (PBA) | Phase 4 | Terminated | St. Joseph's Hospital and Medical Center, Phoenix | 34 | 2012-08-28 | 2019-10-29 |
| Optimisation of Antipsychotic Drug Use in Older People Patients- dose titration - Alzheimer's Disease, Schizophrenia | Phase 4 | Terminated | Institute of Psychiatry, London | 64 | 2012-05-01 | 2017-04-19 |
| The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease Galantamine - Alzheimer Disease | Phase 4 | Terminated | Janssen-Cilag, S.A. | 1 | 2011-05-01 | 2014-05-01 |
| Memantine and Antipsychotics Use Memantine - Alzheimer's Disease | Phase 4 | Terminated | Merz Pharmaceuticals GmbH | 19 | 2008-07-01 | 2011-09-26 |
| Modafinil Treatment for Sleep/Wake Disturbances in Older Adults modafinil - Insomnia, Sleep Initiation and Maintenance Disorders | Phase 4 | Terminated | VA Palo Alto Health Care System | 2 | 2008-02-01 | 2019-10-28 |
| Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients Razadyne ER, Aricept - Alzheimer's Disease | Phase 4 | Terminated | Duke University | 4 | 2006-10-01 | 2013-04-11 |
| Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients DONEPEZIL HYDROCHLORIDE - Alzheimer's Disease | Phase 4 | Terminated | Eisai Korea Inc. | 40 | 2005-03-01 | 2013-11-20 |
Alzheimer Disease (8) · Dementia (2) · Cognitive Dysfunction (1) · Fatigue (1) · Lethargy (1) · Schizophrenia (1) · Sleep Initiation and Maintenance Disorders (1) · Sleep Wake Disorders (1)
Brain Diseases (8) · Central Nervous System Diseases (8) · Mental Disorders (8) · Nervous System Diseases (8) · Neurocognitive Disorders (8) · Neurodegenerative Diseases (8) · Dementia (6) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Neurologic Manifestations (2) · Cognition Disorders (1) · Dyssomnias (1) · Neurobehavioral Manifestations (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
Donepezil (2) · Galantamine (2) · Memantine (1) · Methylphenidate (1) · Modafinil (1) · dextromethorphan - quinidine combination (1)
Duke University (1) · Eisai Korea Inc. (1) · Institute of Psychiatry, London (1) · Janssen-Cilag, S.A. (1) · Merz Pharmaceuticals GmbH (1) · St. Joseph's Hospital and Medical Center, Phoenix (1) · St. Louis University (1) · VA Palo Alto Health Care System (1)
United States (4) · Germany (1) · South Korea (1) · Spain (1) · United Kingdom (1)
Ahmed A Baig, M.D. (1) · George T Grossberg, M.D. (1) · James R Burke, PhD (1) · Jamie M Zeitzer, PhD (1) · Jeffrey N Browndyke, PhD (1) · Jihee Mun (1) · Jiong Shi, MD, PhD (1) · Kathleen Welsh-Bohmer, PhD (1) · Roberto Cabeza, PhD (1) · Suzanne J Reeves, MBChB, PhD (1)
2009 (1)